Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERASIROX vs DEFIBROTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERASIROX vs DEFIBROTIDE: Safety Overview

Metric DEFERASIROX DEFIBROTIDE
Total FAERS Reports 11,322 3,740
Deaths Reported 2,661 1,804
Death Rate 23.5% 48.2%
Hospitalizations 4,008 832
Average Patient Age 49.8 yrs 36.3 yrs
% Female Patients 50.1% 38.7%
FDA Approval Date Apr 11, 2025 Mar 30, 2016
Manufacturer AvKARE Jazz Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription